MedPath

Cervical Transforaminal Injection of Steroids Guided by Ultrasound

Not Applicable
Conditions
Cervical Radiculopathy
Interventions
Procedure: SNR steroid (dexamethasone) injection
Procedure: CTF steroid (dexamethasone) injection
Drug: Dexamethasone
Device: Ultrasound
Radiation: C arm
Registration Number
NCT02295709
Lead Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Brief Summary

Cervical transforaminal epidural steroid injections (TFESI) are indicated in cervical radicular pain resistant to conservation therapy, by which steroids can be delivered into anterior epidural space surrounding target spinal nerve roots to help alleviate pain in the upper limb or neck. Cervical TFESI is traditionally commended to perform with guidance of fluoroscopy or CT. As fluoroscopy can not monitor the injection route whether it pass vessel or not, many serious neurological complications caused by inadvertent intra-arterial injection have been reported2. Here, the investigators will introduce a novel cervical TFESI guided by ultrasound, which incidence of inadvertent vessel injury or injection might be lower than those guided by fluoroscopy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • evidence of a cervical radiculopathy involving 1 spinal nerve of at least 1 month's duration refractory to medical treatment
  • symptoms of cervical pain radiating to the upper limb
  • and signs of altered sensations, ab- normal reflexes, or motor weakness caused by degenerative spondylosis and/or disk herniation as documented at CT or MR imaging and a current mean pain VAS score of six.

Exclusion criteria:

  • evidence of vertebral fracture, tumor, or infection of the cervical spine
  • treatment with cervical corticosteroid injections within the past 3 months
  • coagulopathy
  • allergy to iodinated contrast media.
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
USNR steroid injectionSNR steroid (dexamethasone) injectionthe patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
UCTF steroid injectionUltrasoundthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
USNR steroid injectionC armthe patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
UCTF steroid injectionCTF steroid (dexamethasone) injectionthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
XCTF steroid injectionCTF steroid (dexamethasone) injectionthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
USNR steroid injectionUltrasoundthe patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
UCTF steroid injectionC armthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
XCTF steroid injectionC armthe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
USNR steroid injectionDexamethasonethe patient who are treated with steroid (dexamethasone) injection through selected cervical spinal nerve block approach guided by ultrasound and C arm.
UCTF steroid injectionDexamethasonethe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided by ultrasound and C arm.
XCTF steroid injectionDexamethasonethe patients who are treated with steroid (dexamethasone) injection through cervical transforaminal approach guided only by C arm.
Primary Outcome Measures
NameTimeMethod
change of pain severity rated on a Visual Analog Scale (VAS)1 day before, 1day after, 1week after and 4 weeks after the intervention
Secondary Outcome Measures
NameTimeMethod
change of medication use rated on Medication Quantitative Scale (MQS)1 day before, 1day after, 1week after and 4 weeks after the intervention
change of neck actives rated on Neck Disability Index (NDI)1 day before, 1day after, 1week after and 4 weeks after the intervention
© Copyright 2025. All Rights Reserved by MedPath